Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 55

    1.

    Vitamin D and cardiovascular disease.

    Gouni-Berthold I, Krone W, Berthold HK.

    Curr Vasc Pharmacol. 2009 Jul;7(3):414-22. Review.PMID: 19601865 [PubMed - indexed for MEDLINE]Related articles

    2.

    The stable isotope ketoisocaproic acid breath test as a measure of hepatic decarboxylation capacity: a quantitative analysis in normal subjects after oral and intravenous administration.

    Berthold HK, Giesen TA, Gouni-Berthold I.

    Liver Int. 2009 Oct;29(9):1356-64. Epub 2009 Jun 23.PMID: 19555399 [PubMed - indexed for MEDLINE]Related articles

    3.

    Use of the lactose-[13C]ureide breath test for diagnosis of small bowel bacterial overgrowth: comparison to the glucose hydrogen breath test.

    Berthold HK, Schober P, Scheurlen C, Marklein G, Horré R, Gouni-Berthold I, Sauerbruch T.

    J Gastroenterol. 2009;44(9):944-51. Epub 2009 Jun 24.PMID: 19551459 [PubMed - in process]Related articles

    4.

    Patterns and predictors of statin prescription in patients with type 2 diabetes.

    Berthold HK, Gouni-Berthold I, Böhm M, Krone W, Bestehorn KP.

    Cardiovasc Diabetol. 2009 May 13;8:25.PMID: 19439071 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Comparison of a new long-acting testosterone undecanoate formulation vs testosterone enanthate for intramuscular androgen therapy in male hypogonadism.

    Minnemann T, Schubert M, Freude S, Hübler D, Gouni-Berthold I, Schumann C, Christoph A, Oettel M, Ernst M, Mellinger U, Krone W, Jockenhövel F.

    J Endocrinol Invest. 2008 Aug;31(8):718-23.PMID: 18852533 [PubMed - indexed for MEDLINE]Related articles

    6.

    The Leu72Met polymorphism of the ghrelin gene is associated with a decreased risk for type 2 diabetes.

    Berthold HK, Giannakidou E, Krone W, Mantzoros CS, Gouni-Berthold I.

    Clin Chim Acta. 2009 Jan;399(1-2):112-6. Epub 2008 Sep 25.PMID: 18848536 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of a cellulose-containing weight-loss supplement on gastric emptying and sensory functions.

    Berthold HK, Unverdorben S, Degenhardt R, Unverdorben M, Gouni-Berthold I.

    Obesity (Silver Spring). 2008 Oct;16(10):2272-80. Epub 2008 Jul 24.PMID: 18719632 [PubMed - indexed for MEDLINE]Related articles

    8.

    Physician gender is associated with the quality of type 2 diabetes care.

    Berthold HK, Gouni-Berthold I, Bestehorn KP, Böhm M, Krone W.

    J Intern Med. 2008 Oct;264(4):340-50. Epub 2008 Apr 4.PMID: 18397244 [PubMed - indexed for MEDLINE]Related articles

    9.

    Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes.

    Gouni-Berthold I, Berthold HK, Mantzoros CS, Böhm M, Krone W.

    Diabetes Care. 2008 Jul;31(7):1389-91. Epub 2008 Mar 28.PMID: 18375411 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.

    Berthold HK, Laaksonen R, Lehtimäki T, Gylling H, Krone W, Gouni-Berthold I.

    Exp Clin Endocrinol Diabetes. 2008 May;116(5):262-7. Epub 2007 Dec 10.PMID: 18072016 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men.

    Gouni-Berthold I, Berthold HK, Gylling H, Hallikainen M, Giannakidou E, Stier S, Ko Y, Patel D, Soutar AK, Seedorf U, Mantzoros CS, Plat J, Krone W.

    Atherosclerosis. 2008 May;198(1):198-207. Epub 2007 Nov 5.PMID: 17980884 [PubMed - indexed for MEDLINE]Related articles

    12.

    Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men.

    Gouni-Berthold I, Berthold HK, Chamberland JP, Krone W, Mantzoros CS.

    Clin Endocrinol (Oxf). 2008 Apr;68(4):536-41. Epub 2007 Oct 31.PMID: 17973945 [PubMed - indexed for MEDLINE]Related articles

    13.

    A four-year efficacy and safety study of the long-acting parenteral testosterone undecanoate.

    Minnemann T, Schubert M, Hübler D, Gouni-Berthold I, Freude S, Schumann C, Oettel M, Ernst M, Mellinger U, Sommer F, Krone W, Jockenhövel F.

    Aging Male. 2007 Sep;10(3):155-8.PMID: 17701659 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Favorable effects of decreasing lipids in patients with diabetes mellitus]

    Gouni-Berthold I, Krone W.

    Dtsch Med Wochenschr. 2006 Dec;131 Suppl 8:S252-4. Review. German. PMID: 17139581 [PubMed - indexed for MEDLINE]Related articles

    15.

    The K121Q polymorphism of the plasma cell glycoprotein-1 gene is not associated with diabetes mellitus type 2 in German Caucasians.

    Gouni-Berthold I, Giannakidou E, Faust M, Berthold HK, Krone W.

    Horm Metab Res. 2006 Aug;38(8):524-9.PMID: 16941279 [PubMed - indexed for MEDLINE]Related articles

    16.

    Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study.

    Voges J, Kocher M, Runge M, Poggenborg J, Lehrke R, Lenartz D, Maarouf M, Gouni-Berthold I, Krone W, Muller RP, Sturm V.

    Cancer. 2006 Sep 15;107(6):1355-64.PMID: 16894526 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial.

    Berthold HK, Naini A, Di Mauro S, Hallikainen M, Gylling H, Krone W, Gouni-Berthold I.

    Drug Saf. 2006;29(8):703-12.PMID: 16872244 [PubMed - indexed for MEDLINE]Related articles

    18.

    Diabetic ketoacidosis and hyperosmolar hyperglycemic state.

    Gouni-Berthold I, Krone W.

    Med Klin (Munich). 2006 Mar 22;101 Suppl 1:100-5.PMID: 16802531 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.

    Berthold HK, Unverdorben S, Degenhardt R, Bulitta M, Gouni-Berthold I.

    JAMA. 2006 May 17;295(19):2262-9.PMID: 16705107 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Association of the promoter polymorphism -232C/G of the phosphoenolpyruvate carboxykinase gene (PCK1) with Type 2 diabetes mellitus.

    Gouni-Berthold I, Giannakidou E, Faust M, Berthold HK, Krone W.

    Diabet Med. 2006 Apr;23(4):419-25.PMID: 16620271 [PubMed - indexed for MEDLINE]Related articles

    21.

    Peroxisome proliferator-activated receptor alpha (PPARalpha) and athero-sclerosis.

    Gouni-Berthold I, Krone W.

    Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec;5(6):513-23. Review.PMID: 16503871 [PubMed - indexed for MEDLINE]Related articles

    22.

    Resistin gene 3'-untranslated region +62G-->A polymorphism is associated with hypertension but not diabetes mellitus type 2 in a German population.

    Gouni-Berthold I, Giannakidou E, Faust M, Kratzsch J, Berthold HK, Krone W.

    J Intern Med. 2005 Dec;258(6):518-26.PMID: 16313475 [PubMed - indexed for MEDLINE]Related articles

    23.

    The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls.

    Gouni-Berthold I, Giannakidou E, Faust M, Berthold HK, Krone W.

    Atherosclerosis. 2005 Dec;183(2):336-41. Epub 2005 Apr 19.PMID: 16285997 [PubMed - indexed for MEDLINE]Related articles

    24.

    Hypertriglyceridemia-why, when and how should it be treated?

    Gouni-Berthold I, Krone W.

    Z Kardiol. 2005 Nov;94(11):731-9. Review.PMID: 16258774 [PubMed - indexed for MEDLINE]Related articles

    25.

    The Pro387Leu variant of protein tyrosine phosphatase-1B is not associated with diabetes mellitus type 2 in a German population.

    Gouni-Berthold I, Giannakidou E, Müller-Wieland D, Faust M, Kotzka J, Berthold HK, Krone W.

    J Intern Med. 2005 Mar;257(3):272-80.PMID: 15715684 [PubMed - indexed for MEDLINE]Related articles

    26.

    Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2.

    Gouni-Berthold I, Giannakidou E, Müller-Wieland D, Faust M, Kotzka J, Berthold HK, Krone W.

    J Hypertens. 2005 Feb;23(2):301-8.PMID: 15662218 [PubMed - indexed for MEDLINE]Related articles

    27.

    Possible non-classic intracellular and molecular mechanisms of LDL cholesterol action contributing to the development and progression of atherosclerosis.

    Gouni-Berthold I, Sachinidis A.

    Curr Vasc Pharmacol. 2004 Oct;2(4):363-70. Review.PMID: 15320816 [PubMed - indexed for MEDLINE]Related articles

    28.

    Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women.

    Berthold HK, Unverdorben S, Zittermann A, Degenhardt R, Baumeister B, Unverdorben M, Krone W, Vetter H, Gouni-Berthold I.

    Osteoporos Int. 2004 Jun;15(6):459-67. Epub 2004 Feb 14.PMID: 15205717 [PubMed - indexed for MEDLINE]Related articles

    29.

    Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls.

    Gouni-Berthold I, Giannakidou E, Müller-Wieland D, Faust M, Kotzka J, Berthold HK, Krone W.

    Am Heart J. 2004 Jun;147(6):1117-24.PMID: 15199365 [PubMed - indexed for MEDLINE]Related articles

    30.

    Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholesterolaemia.

    Weinbrenner T, Züger M, Jacoby GE, Herpertz S, Liedtke R, Sudhop T, Gouni-Berthold I, Axelson M, Berthold HK.

    Br J Nutr. 2004 Jun;91(6):959-69.PMID: 15182399 [PubMed - indexed for MEDLINE]Related articles

    31.

    Regulation of mitogen-activated protein kinase cascades by low density lipoprotein and lysophosphatidic acid.

    Gouni-Berthold I, Seewald S, Hescheler J, Sachinidis A.

    Cell Physiol Biochem. 2004;14(3):167-76.PMID: 15107593 [PubMed - indexed for MEDLINE]Related articles

    32.

    Short-term effects of high soy supplementation on sex hormones, bone markers, and lipid parameters in young female adults.

    Zittermann A, Geppert J, Baier S, Zehn N, Gouni-Berthold I, Berthold HK, Reinsberg J, Stehle P.

    Eur J Nutr. 2004 Apr;43(2):100-8. Epub 2004 Jan 6.PMID: 15083317 [PubMed - indexed for MEDLINE]Related articles

    33.

    Molecular mechanisms explaining the preventive effects of catechins on the development of proliferative diseases.

    Gouni-Berthold I, Sachinidis A.

    Curr Pharm Des. 2004;10(11):1261-71. Review.PMID: 15078140 [PubMed - indexed for MEDLINE]Related articles

    34.

    Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control study.

    Weinbrenner T, Zittermann A, Gouni-Berthold I, Stehle P, Berthold HK.

    Eur J Clin Nutr. 2003 Oct;57(10):1262-7.PMID: 14506487 [PubMed - indexed for MEDLINE]Related articles

    35.

    Inhibition of the Low Density Lipoprotein-Induced Vascular Smooth Muscle Cell Growth by PPARgamma Ligands.

    Gouni-Berthold I, Sachinidis A.

    Drug News Perspect. 2002 Jan;15(1):5-9.PMID: 12677238 [PubMed - as supplied by publisher]Related articles

    36.

    Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells?

    Gouni-Berthold I, Sachinidis A.

    FASEB J. 2002 Oct;16(12):1477-87. Review.PMID: 12374770 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea.

    Schäfer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK.

    Chest. 2002 Sep;122(3):829-39.PMID: 12226021 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent.

    Gouni-Berthold I, Berthold HK.

    Am Heart J. 2002 Feb;143(2):356-65. Review.PMID: 11835043 [PubMed - indexed for MEDLINE]Related articles

    39.

    Gangliosides GM1 and GM2 induce vascular smooth muscle cell proliferation via extracellular signal-regulated kinase 1/2 pathway.

    Gouni-Berthold I, Seul C, Ko Y, Hescheler J, Sachinidis A.

    Hypertension. 2001 Nov;38(5):1030-7.PMID: 11711493 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth.

    Gouni-Berthold I, Berthold HK, Weber AA, Seul C, Vetter H, Sachinidis A.

    Exp Clin Endocrinol Diabetes. 2001;109(4):203-9.PMID: 11453032 [PubMed - indexed for MEDLINE]Related articles

    41.

    Effects of authentic and VLDL hydrolysis-derived fatty acids on vascular smooth muscle cell growth.

    Gouni-Berthold I, Berthold HK, Seul C, Ko Y, Vetter H, Sachinidis A.

    Br J Pharmacol. 2001 Apr;132(8):1725-34.PMID: 11309244 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Short-term stimulation of vascular smooth muscle cells with platelet-derived growth factor (PDGF)-BB and angiotensin II induces.

    Gouni-Berthold I, Berthold HK, Seewald S, Seul C, Ko Y, Vetter H, Sachinidis A.

    Scand J Clin Lab Invest. 2000 Dec;60(8):723-31.PMID: 11218155 [PubMed - indexed for MEDLINE]Related articles

    43.

    Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway.

    Gouni-Berthold I, Berthold HK, Weber AA, Ko Y, Seul C, Vetter H, Sachinidis A.

    Naunyn Schmiedebergs Arch Pharmacol. 2001 Feb;363(2):215-21.PMID: 11218074 [PubMed - indexed for MEDLINE]Related articles

    44.

    Dinucleotides as growth-promoting extracellular mediators. Presence of dinucleoside diphosphates Ap2A, Ap2G, and Gp2G in releasable granules of platelets.

    Jankowski J, Hagemann J, Tepel M, van Der Giet M, Stephan N, Henning L, Gouni-Berthold I, Sachinidis A, Zidek W, Schluter H.

    J Biol Chem. 2001 Mar 23;276(12):8904-9. Epub 2000 Dec 13. Erratum in: J Biol Chem 2001 Jun 8;276(23):20803. Gouni-Berthold, H [corrected to Gouni-Berthold, I]. PMID: 11115507 [PubMed - indexed for MEDLINE]Related articles

    45.

    Cholera toxin treatment of vascular smooth muscle cells decreases smooth muscle alpha-actin content and abolishes the platelet-derived growth factor-BB-stimulated DNA synthesis.

    Sachinidis A, Seul C, Gouni-Berthold I, Seewald S, Ko Y, Vetter H, Fingerle J, Hoppe J.

    Br J Pharmacol. 2000 Aug;130(7):1561-70.PMID: 10928958 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    High percentage of false-positive results of cytokeratin 19 RT-PCR in blood: a model for the analysis of illegitimate gene expression.

    Ko Y, Grünewald E, Totzke G, Klinz M, Fronhoffs S, Gouni-Berthold I, Sachinidis A, Vetter H.

    Oncology. 2000 Jun;59(1):81-8.PMID: 10895072 [PubMed - indexed for MEDLINE]Related articles

    47.

    Differential gene expression in synovium of rheumatoid arthritis and osteoarthritis.

    Jüsten HP, Grünewald E, Totzke G, Gouni-Berthold I, Sachinidis A, Wessinghage D, Vetter H, Schulze-Osthoff K, Ko Y.

    Mol Cell Biol Res Commun. 2000 Mar;3(3):165-72.PMID: 10860865 [PubMed - indexed for MEDLINE]Related articles

    48.

    Early intracellular signalling pathway of ethanol in vascular smooth muscle cells.

    Sachinidis A, Gouni-Berthold I, Seul C, Seewald S, Ko Y, Schmitz U, Vetter H.

    Br J Pharmacol. 1999 Dec;128(8):1761-71.PMID: 10588932 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Lipid-induced changes in vascular smooth muscle cell membrane fluidity are associated with DNA synthesis.

    Sachinidis A, Carniel M, Seewald S, Seul C, Gouni-Berthold I, Ko Y, Vetter H.

    Cell Prolif. 1999 Apr-Jun;32(2-3):101-5.PMID: 10535356 [PubMed - indexed for MEDLINE]Related articles

    50.

    Neutrophil-elastase in chronic inflammatory bowel disease: a marker of disease activity?

    Gouni-Berthold I, Baumeister B, Wegel E, Berthold HK, Vetter H, Schmidt C.

    Hepatogastroenterology. 1999 Jul-Aug;46(28):2315-20.PMID: 10521989 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...